Nathan Connell: Calling All Hematology Professionals Interested in Quality Improvement!
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
”Calling All Hematology Professionals Interested in Quality Improvement!
The application window is OPEN for the American Society of Hematology (ASH) Quality Improvement Training Institute (QITI)—a phenomenal, 16-month hybrid program designed to build clinician leadership and drive systems-based change in hematologic care.
This is a must for anyone looking to advance their career in systems-based hematology and become a leader in quality improvement.
Why QITI stands out:
- Hands-on Experience: Teams work on two structured QI projects at their home institution, directly addressing clinical gaps and enhancing patient experience, outcomes, and equity.
- Expert Coaching: Each team is paired with an experienced QI coach for individualized, 16-month mentorship.
- Free to Participate: ASH covers travel, lodging, and meal expenses for up to three team members attending the mandatory in-person workshops in Washington, DC.
QITI is designed for interdisciplinary care teams in North America. If you are passionate about continuous improvement and want to formally integrate QI methodology into your practice, this is your chance!
The 2026-2027 application closes January 5, 2026.
Learn more and apply here.”
Stay updated on all opportunities with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show